ArticleBriefings in bioinformatics2025
MINERVA-microbiome network research and visualization atlas: a scalable knowledge graph for mapping microbiome-disease associations.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Methodological and statistical concerns in MINERVA microbiome-disease knowledge graph.Briefings in bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Bacterial pathogens contribute significantly to the global burden of disease. Understanding their complex interactions with human health is essential for developing new diagnostic, preventative, and therapeutic strategies. While recent breakthroughs have revolutionized our understanding of these relationships, the rapid expansion of microbiome research presents a significant challenge: knowledge remains scattered across scientific literature, hindering comprehensive analysis and clinical translation. To address this, we introduce MINERVA (Microbiome Network Research and Visualization Atlas), an innovative platform that leverages a fine-tuned large language model to systematically map microbe-disease associations across extensive scientific literature. MINERVA constructs a rich, ontology-driven knowledge graph that prioritizes accuracy and transparency, enabling efficient exploration and discovery of previously hidden associations relevant to clinical decision-making. The platform features specialized modules that allow researchers to analyze individual microbes and diseases, visualize complex relationships within the knowledge network, uncover hidden connections through advanced graph algorithms and machine-learning models, and perform personalized and population-level microbiome compositional analysis. These capabilities facilitate the identification of disease risks, comorbidities, and actionable insights, supporting both research and clinical decision-making. By bridging the gap between microbiome research and real-world applications, MINERVA has the potential to transform our understanding of microbe-disease interactions, accelerating discoveries and advancing patient care. The MINERVA platform is available at https://minervabio.org/.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.